" so the company must presumably be seeing some positive
outcomes to continue with the cost?? "
LOL thats a bit of an understatement I reckon .
I guess so many holders are a bit bamboozled as to what constitutes a good announcement , as the R & D work that IMU are doing is pretty cutting edge ...and there are so many steps of progression ....
Setting aside the disappointment as where the current share price is , any body who doesn't think IMU are making stellar progress on a number of fronts ...likely just doesn't understand how these these things work ... or is .... ( I'll be tactful .... but will leave it to others to fill in the gap ............ )
Its a bit like a mineral explorations company ...reporting indicative chemistry in the geology of an area they might be pospecting .... ( means zippo to most ...but could mean something very significant some time down the track )
I just lifted a couple of pages off the ASX website .... and I'd say there are some very very significant announcements there .... but most fall on deaf ears unfortunately , and I couldn't be rooted trying to explain each one .... .
Look to Davey for those very interesting explanations and analysis ...he is just so generous with his time and input .
Better still spend some time on the website .... its a wealth of info
cheers to all including all the non believers ....
LOL
Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8 0 30 Sep 20245:01pm 5:01pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Change of Director's Interest Notice - PH opens new window256KB 256KB
- Change of Director's Interest Notice
1 18 Sep 20241:06pm 1:06pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Imugene Receives Orphan Drug Designation for VAXINIA opens new window237KB 237KB
- Progress Report
2 11 Sep 20244:59pm 4:59pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Appendix 2A opens new window435KB 435KB
- Appendix 2A
3 9 Sep 202410:12am 10:12am IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Imugene Corporate Presentation opens new window3657KB 3657KB
- Company Presentation
4 4 Sep 20244:32pm 4:32pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Cleansing Notice opens new window198KB 198KB
- Cleansing Notice
5 4 Sep 20244:29pm 4:29pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Application for quotation of securities - IMU opens new window17KB 17KB
- Appendix 2A
6 4 Sep 202410:19am 10:19am IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Imugene Azer-cel Webinar Presentation opens new window1405KB 1405KB
- Company Presentation
7 3 Sep 20248:26am 8:26am IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Imugene Webinar - Azer-cel Trial Update opens new window211KB 211KB
- Web Cast
8 2 Sep 20248:44am 8:44am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Three Complete Responses in Azer-Cel Phase 1b Trial opens new window319KB 319KB
- Progress Report
9 30 Aug 20246:44pm 6:44pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Imugene ESG Report 2024 opens new window2840KB 2840KB
- Periodic Reports - Other
10 30 Aug 20246:43pm 6:43pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Corporate Governance Statement 2024 and Appendix 4G opens new window671KB 671KB
- Corporate Governance and 1 more
11 30 Aug 20246:43pm 6:43pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Appendix 4E and Annual Report opens new window5710KB 5710KB
- Annual Report and 6 more
12 2 Aug 20245:59pm 5:59pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Release of Shares from Voluntary Escrow opens new window130KB 130KB
- Issued Capital - Other
13 31 Jul 20249:16am 9:16am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Quarterly Activities/Appendix 4C Cash Flow Report opens new window458KB 458KB
- Commitments Test Entity - Fourth Quarter Activity Report and 1 more
14 12 Jul 20245:28pm 5:28pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Notification of cessation of securities - IMU opens new window16KB 16KB
- Appendix 3H (Notification of cessation of securities)
15 12 Jul 20245:19pm 5:19pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Notification regarding unquoted securities - IMU opens new window19KB 19KB
- Appendix 3G
16 10 Jul 20249:20am 9:20am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes First patient dosed in Phase 1 bile tract cancer trial opens new window368KB 368KB
- Progress Report
17 8 Jul 20244:50pm 4:50pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Change of Director's Interest Notice x6 opens new window49KB 49KB
- Change of Director's Interest Notice
18 8 Jul 202411:20am 11:20am IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Application for quotation of securities - IMU opens new window22KB 22KB
- Appendix 2A
19 4 Jul 20243:44pm 3:44pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Imugene Corporate Presentation opens new window2106KB 2106KB
- Company Presentation
20 24 Jun 20248:24am 8:24am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Imugene onCARlytics Doses First Patient in IV Combination opens new window169KB 169KB
- Progress Report
21 30 May 202412:06pm 12:06pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Imugene Presentation to Bell Potter Conference opens new window1802KB 1802KB
- Company Presentation
22 6 May 20244:10pm 4:10pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Application for quotation of securities - IMU opens new window17KB 17KB
- Appendix 2A
23 30 Apr 20248:48am 8:48am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Quarterly Activities/Appendix 4C Cash Flow Report opens new window484KB 484KB
- Commitments Test Entity - Third Quarter Activity Report and 1 more
24 23 Apr 20244:50pm 4:50pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Change of Director's Interest Notice - PH opens new window4KB 4KB
- Change of Director's Interest Notice
Go look for your self for the missing ones .... LOL
{caption}Announcments results{/caption} 1 DATE /TIME TIME CODE /COMPANY NAME COMPANY NAME PRICE SENSITIVEPRICESENSITIVE HEADLINE /DOC SIZE DOC SIZE TYPE 2 17 Jan 20249:39am 9:39am IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Notification regarding unquoted securities - IMU opens new window40KB 40KB
- Appendix 3G
3 10 Jan 202410:58am 10:58am IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Imugene Presentation to JPMorgan Healthcare Conference opens new window4438KB 4438KB
- Company Presentation
4 12 Dec 20239:28am 9:28am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Imugene and NeoImmuneTech to Improve Cancer Treatments opens new window193KB 193KB
- Progress Report
5 11 Dec 20239:01am 9:01am IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Imugene to Present at Annual JPMorgan Healthcare Conference opens new window164KB 164KB
- Web Cast
6 6 Dec 20236:32pm 6:32pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Application for quotation of securities - IMU opens new window26KB 26KB
- Appendix 2A
7 6 Dec 20239:31am 9:31am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes New PD1-Vaxx Phase 2 CRC Cancer Trial to Open in UK and AUS opens new window176KB 176KB
- Progress Report
8 6 Dec 20238:50am 8:50am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Europe Patent to be Granted for PD1-Vaxx Cancer Vaccine opens new window127KB 127KB
- Progress Report
9 30 Nov 20235:30pm 5:30pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Results of Meeting opens new window191KB 191KB
- Results of Meeting
10 30 Nov 20232:03pm 2:03pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no AGM Presentation opens new window3099KB 3099KB
- Company Presentation and 1 more
11 28 Nov 20238:53am 8:53am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes FDA Fast Track Designation Granted for VAXINIA Trial Program opens new window161KB 161KB
- Progress Report
12 14 Nov 20234:38pm 4:38pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Investor Webinar featuring COO, Dr Glover & CMO, Dr Woodard opens new window119KB 119KB
- Web Cast
13 10 Nov 20239:03am 9:03am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Azer-cel Hits Major Milestone in Phase 1b CAR T Trial opens new window193KB 193KB
- Progress Report
14 7 Nov 20231:05pm 1:05pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Imugene Investor Webinar - MAST Study Update opens new window119KB 119KB
- Web Cast
15 6 Nov 20239:54am 9:54am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Phase 1 CF33 VAXINIA Study Update - Positive Early Signals opens new window179KB 179KB
- Progress Report
16 2 Nov 20239:39am 9:39am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Next cohort reached in IV arms of CF33-hNIS (VAXINIA) study opens new window174KB 174KB
- Progress Report
17 31 Oct 20236:19pm 6:19pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Amended Annual Report opens new window4292KB 4292KB
- Annual Report and 5 more
18 31 Oct 20239:05am 9:05am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Quarterly Activities/Appendix 4C Cash Flow Report opens new window488KB 488KB
- Commitments Test Entity - First Quarter Activity Report and 1 more
19 30 Oct 20237:00pm 7:00pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Notice of Annual General Meeting/Proxy Form opens new window1073KB 1073KB
- Notice of Annual General Meeting and 1 more
20 26 Oct 20239:08am 9:08am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Imugene Phase 1 onCARlytics CD19 virus clinical trial opens opens new window148KB 148KB
- Progress Report
21 24 Oct 20239:44am 9:44am IMUGENE LIMITED
- IMU
IMUGENE LIMITED yes Imugene B Cell & OV Platforms Featured at ESMO Congress opens new window172KB 172KB
- Progress Report
22 12 Oct 20236:01pm 6:01pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Change of Director's Interest Notice - PH opens new window5KB 5KB
- Change of Director's Interest Notice
23 11 Oct 20237:39pm 7:39pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Change of Director's Interest Notice - LC opens new window8KB 8KB
- Change of Director's Interest Notice
24 4 Oct 20237:25pm 7:25pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Change of Director's Interest Notice - PH opens new window5KB 5KB
- Change of Director's Interest Notice
25 4 Oct 20237:18pm 7:18pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Change of Director's Interest Notice - JD opens new window4KB 4KB
- Change of Director's Interest Notice
26 4 Oct 20237:17pm 7:17pm IMUGENE LIMITED
- IMU
IMUGENE LIMITED no Change of Director's Interest Notice - JE opens new window4KB 4KB
- Change of Director's Interest Notice
Page 3
51 to- 75 of 1,049 results
- Forums
- ASX - By Stock
- Media Thread
" so the company must presumably be seeing some positive...
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.4¢ |
Change
-0.002(4.35%) |
Mkt cap ! $327.2M |
Open | High | Low | Value | Volume |
4.6¢ | 4.6¢ | 4.3¢ | $1.410M | 31.79M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 4222156 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 2208592 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 4222156 | 0.043 |
37 | 4480784 | 0.042 |
25 | 3146590 | 0.041 |
60 | 4441108 | 0.040 |
22 | 3469031 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 2208592 | 2 |
0.045 | 2487440 | 8 |
0.046 | 3650874 | 12 |
0.047 | 1461855 | 9 |
0.048 | 2381107 | 11 |
Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |